ABSTRACT
INTRODUCTION
Type 2 diabetes mellitus (DM) which has devastating consequences on life expectancy and quality of life, imposes large economic costs, and currently affects 8.2% of the Malaysian population (1) . Despite major advances in the treatment of hyperglycemia, risk factors for cardiovascular disease (CVD) and other diabetes complications, type 2 DM remains a chronic degenerative condition that is difficult to treat (2) . Type 2 DM results from the interaction between genetic predisposition, behavioral and environmental risk factors (3) . Although the genetic basis of type 2 DM has yet to be identified there is strong evidence that such modifiable risk factors as obesity and physical inactivity are the main non genetic determinants of the disease (4, 5, 6) . Prevention of diabetes is a worthy cause especially as diabetes is linked to contemporary lifestyle (7) . Recently the Diabetes Prevention Programme has shown that it was possible to prevent or delay diabetes among individuals at high risk for diabetes, regardless of sex, age and race/ethnicity (8) . The diagnosis of diabetes mellitus is based on an elevated plasma glucose concentration in the fasting state and after an oral glucose load. The complications of diabetes are influenced not only by the duration of diabetes but also by the average level of chronic hyperglycemia (9) which is measured most reliably with the HbA 1C assay. Impaired glucose tolerance is an intermediate category between normal glucose tolerance and overt diabetes (10, 11) and it can be identified by the response to a oral glucose tolerance test. Subjects with impaired glucose tolerance have an increased risk of type 2 DM (12) . The aim of this study is to evaluate the usefulness of HbA 1C as an early marker in nondiabetic high risk group. In our study the group consisted of adults whose parents were diabetic and who form an important target group for early intervention aimed at preventing diabetes.
MATERIALS AND METHODS

Subjects:
One hundred and forty seven adult individual men and women were recruited from Klang Valley and from the diabetic clinic of University of Malaya Medical centre. They were classified into one of three groups; diabetic (n=11), offspring (first degree relatives) of one type 2 DM parent (n=57) or normal (n = 90). The exclusion criteria for first degree relatives as determined by questionnaire responses were a history of cardiovascular disease, diabetes, hypertension, dyslipidaemia, pregnancy, any permanent illness or incapability of fasting for eight hours. Informed consent was obtained from all subjects and the study was approved by University of Malaya, Faculty of Medicine's Medical ethics committee and carried out in accordance with the Helsinki declaration.
Blood sample collection: Ten milliliters of fasting blood from each recruit was collected in Vacutainer TM tubes containing disodium ethylene diamine tetraacetate (EDTA, 1mg/mL) or containing glycolysis inhibitor (fluoride) or serum separator (SST) for the various tests after an overnight fast of eight hours. For oral glucose tolerance test (OGTT), glucose (75g) was given orally to all participants and another venous blood sample 5mL was collected again after two hours. Blood samples were then subjected to estimation of fasting plasma glucose (FPG), plasma glucose after two hours of glucose challenge (postprandial, PPBG), fasting lipid (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides) and HbA 1C .
Classification of Subjects :
The subjects are classified as having impaired glucose tolerance (IGT) if the two hours plasma glucose (postprandial) level is between 7.8 and 11.0 mmol/L. The subjects are classified as having normal glucose tolerance if the FBG was less than 5.6 mmol/L and the two hours plasma glucose level was less than 7.8 mmol/L as recommended by the American Diabetes Association 2003 (13) . They were classified as diabetic if FPG was more than 7.0 mmol/L or if the two hours plasma glucose was more than 11.1 mmol/L. None of the subjects received hypolipidemic drug therapy, or had any renal, hepatic or thyroid disease affecting glucose or lipid metabolism.
Estimation of lipids, FBG, PPBG, and HbA 1C : HbA 1C was determined by immunoassay using Cobas Integra 800 ( Roche Diagnostics, USA). Plasma was separated immediately by centrifugation at 3000 rpm for 15 minutes at 4°C. Total cholesterol, triglycerides and high density lipoprotein (HDL) were determined using the Dimension clinical chemistry system (Dade Behring Systems, France), and low density lipoprotein (LDL) was determined by using Friedewald's equation (14) . Glucose was determined using the Dimension clinical chemistry system based on the hexokinase-glucose-6-phosphate dehydrogenase system. Statistical Analysis : Data were expressed as mean ± standard deviation. Continuous variables were analyzed using one way ANOVA. Two tailed p value of less than 0.05 was considered significant. For most of the variables, the Levene's test of equality of variances across groups gave p values which were less than 0.05. Thus equality of variances could not be assumed in most cases. Pairwise multiple comparisons were done using Dunnett's T3 test.
RESULTS
The mean age for all participants was 44.5 (not significantly different by the Dunnett's test) and the mean BMI was 26.8 (not significantly different). The anthropometric values and the blood pressure determinations of the diabetics, the first degree relatives and the nondiabetic normals are shown in Table 1 . There were no significant differences in the anthropometric measures between the three groups. The systolic blood pressure was significantly higher in the diabetics compared to the normal and the first degree relatives but there was no difference between the normals and the first degree relatives. The levels of blood glucose after two hours of oral glucose administration (PPBG), HbA 1C , total cholesterol, triglyceride, high density lipoprotein, and low density lipoprotein are shown in Table 2 . The fasting glucose was significantly higher in the diabetics as compared to the normals and the first degree relatives, but there was no significant differences between the normals and the first degree relatives. The two hour glucose determination was significantly higher in the diabetics as compared to the normals and the first degree relatives. The first degree relative demonstrated higher post prandial glucose levels compared to the normals. The HbA 1C was significantly higher in the diabetics as compared to the normals and the first degree relatives. The interesting finding in this study is that the HbA 1C was significantly higher in the first degree relatives as compared to the normals. with it are one of the major causes of death in Malaysia. Its causes and progress are commonly traced to interacting genetic and behavioral factors. Glucose toxicity is a well established entity that has been shown in type 2 diabetes to cause progressive impairment in insulin secretion and finally leads to insulin resistance (15) . In theory treating diabetes mellitus should be simple -just prevent hyperglycemia from causing damage to organs, and not allow hypoglycemia to cause coma as energy supply to brain fails. It is also known that poor glycemic control is an important factor in the generation of increased protein oxidation in type 2 diabetic patients clinically free of complications (16) . In practice it is not so simple to monitor the glucose levels as they fluctuates all the time. The only effective way is to monitor HbA 1C levels which gives the average blood glucose level of the preceding two or three months (17) .
DISCUSSION
Type 2 diabetes mellitus and the complications associated
HbA 1C has been widely used as a measure of glycemic control in patients with diabetes mellitus. It has been shown that a HbA 1C value of 6.5% is an adequate and useful supportive marker to diagnose diabetes because of its high specificity (18) . A borderline (5.6 to 6.4%) or high (≥ 6.5%) level of HbA 1C was found to strongly predict future drug treatment for diabetes (19) . It has also been shown that that the HbA 1C levels showed a (22) . It has also been shown that HbA 1C determination in high risk patient to be a convenient alternative to fasting plasma glucose or OGTT to diagnose DM (23) . Since poor glycemic control and age related pathology with duration of diabetes are thought to accelerate degenerative changes in a cooperative manner (24) , it is better to identify the people at high risk group during the prediabetic stage.
